Kalbe Farma Tbk vs Multi Indocitra Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while Multi Indocitra Tbk. trades at Rp530 (market cap 303B, 154.1K 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 108.9× Multi Indocitra Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (98.44M versus 154.1K). Which is the better fit depends on your goals.
| KLBF | MICE | |
|---|---|---|
Market Cap | 33T | 303B |
Volume | 98.44M | 154.1K |
Lot | 984.38K | 1.54K |
Turnover | 70.64B | 81.24M |
Average Price | 717.58 | 527.17 |
Value | 70.64B | 81.24M |
Indicative Equilibrium Price | 720 | — |
Indicative Equilibrium Volume | 43.62K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT Multi Indocitra Tbk (the Company) was established under its original name of Modern Indocitra based on notarial deed No. 52 of Esther Daniar Iskandar, S.H dated January 11, 1990. The Company's articles of association has been amended several times, the latest amendment dated Aug 16, 2005, regarding the change in the Company's status from private company to public company.
Read more on MICE →